{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidcnohrgzh7w2sjh46nuyzlwraod6bs7h6udg67avpf2bd2zoyhzi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mnd7urkyx3f2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidlh62sd4zkbmnpyjq7633pdvp374of62zdoobjyrrcc34zoj6umm"
    },
    "mimeType": "image/jpeg",
    "size": 518321
  },
  "path": "/news/2026-06-gut-bacteria-fecal-transplants-small.html",
  "publishedAt": "2026-06-02T13:20:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Researchers at the Icahn School of Medicine at Mount Sinai have developed a new manufacturing platform for producing targeted mixtures of beneficial gut bacteria, an approach that could help expand access to microbiome-based therapies for patients with recurrent Clostridioides difficile (C. difficile) infection.",
  "title": "Engineered gut bacteria match fecal transplants in small C. difficile trial"
}